Third Affiliated Hospital, Sun Yat-sen University

This study is observing how well the approved MS medication ofatumumab works and how safe it is for Chinese patients in real-world settings. It will follow 80 adults with relapsing MS to see if the drug reduces a blood marker linked to nerve damage. The goal is to gather more evi…

This study is testing a two-step blood filtering treatment for people with sudden liver failure on top of chronic liver disease who also have a severe bloodstream infection (sepsis). Researchers want to see if this procedure, which removes harmful inflammatory substances from the…